Abstract
We used intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) to explore the possibility of preoperative diagnosis of soft tissue tumors (STTs). This prospective study enrolled 23 patients. Conventional MRI and IVIM examinations were performed on a 3.0T MR imager. Eight (35%) hemangiomas, 11 (47%) benign soft tissue tumors excluding hemangiomas (BSTTEHs) and 4 soft tissue sarcomas (STSs) were assessed. The mean tumor size was about 1652.36 ± 233.66 mm2. Ten b values (0–800 s/mm2) were used to evaluate diffusion and perfusion characteristics of IVIM. IVIM parameters (ADCstandard, ADCslow, ADCfast, and f) of STTs were measured and evaluated for differentiating hemangiomas, BSTTEHs, and STSs. ADCslow and ADCfast value were different for hemangiomas, BSTTEHs, and STSs separately (P < 0.001, P < 0.001, and P = 0.001). ADCslow, cut-off value smaller than 0.93 × 10–3 mm2/s, was the best parameter to differ STSs (0.689 ± 0.173 × 10−3 mm2/s) from hemangiomas (0.933 ± 0.237 × 10−3 mm2/s) and BSTTEHs (1.156 ± 0.120 × 10−3 mm2/s) (P = 0.001). ADCslow (0.93 × 10−3 mm2/s <cut-off value <0.96 × 10−3 mm2/s) was used to distinguish hemangiomas from BSTTs. There were significant difference among hemangiomas, BSTTEHs, and STSs (P = 0.014, P = 0.036, P < 0.001). The ADCstandard, ADCfast, and f value were different (P < 0.05) for STSs (1.009 ± 0.177 × 10−3 mm2/s, 15.700 ± 1.992 × 10−3 mm2/s, 0.503 ± 0.068), hemangiomas (1.505 ± 0.226 × 10−3 mm2/s, 11.675 ± 0.456 × 10−3 mm2/s, 0.682 ± 0.060), and BSTTEHs (1.555 ± 0.176 × 10−3 mm2/s, 11.727 ± 0.686 × 10−3 mm2/s, 0.675 ± 0.054). And there was no significant difference for these 3 parameters between hemangiomas and BSTTEHs (P = 0.584, 0.907, and 0.798). IVIM may be of significant value for differential diagnosing hemangiomas, BSTTEHs, and STSs.
INTRODUCTION
Soft tissue tumors (STTs), putatively mesenchymal origin, are sporadic without a known pathogenesis or established risk factors. There is a rising incidence in recent years for benign soft tissue tumors (BSTTs) more than 300/100,000 and malignant ones around 5/100,000 per year.1 In addition, STTs represent a striking range of morphologic diversity and multiple individual clinical symptoms among different types.2 Differential diagnosis of benign tumors and malignant ones should be made for further treatment in clinic. Soft tissue sarcomas (STSs), as the main malignant tumors, occur at any age and account for only 21% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers.3 It is difficult to make a prospectively preoperative diagnosis of different subtypes of STTs due to their complexity and rarity.
Magnetic resonance imaging (MRI) is considered the first choice of imaging modality to evaluate STTs.4 However, there still are lots of problems need to be dealt with. For example, BSTTs may achieve dedifferentiation and exhibit hybrid histologic characteristics of malignant propensity. In addition, hemangiomas, accounting for 7% of BSTTs,5 show diffuse growth and easy to relapse, which is the main cause of clinical misdiagnosis as malignant tumor. It is reported that MR imaging cannot reliably distinguish benign and malignant lesions when radiologic evaluation is nonspecific.6 The inhomogeneity of lesions on T2, the change from homogeneity on T1 to inhomogeneity on T2 sequence, and the involvement of bone or neurovascular structures are features that may be helpful in differential diagnosing benign from malignant soft tissue masses, while whether MRI can be used to differentiate benign from malignant ones is still controversial.7
Intravoxel incoherent motion (IVIM) imaging is an extension of diffusion weighted imaging (DWI) that integrates the apparent diffusion coefficient (ADC) contains both perfusion and diffusion terms.8 Diffusion and perfusion are physically and biologically different phenomena.9 The diffusion property of tumor tissues largely depends on cell density, which may also be predictive features of malignancy in some types of tumors. Perfusion is an important phenomenon of many physiological or pathological processes.8 It is reported that IVIM imaging may be helpful for differentiating benign and malignant salivary gland tumors.10 Therefore, to estimate these 2 distinctive phenomena in tumor tissues may be helpful in the diagnosis of STTs before surgery.
The purpose of the present study was to assess the IVIM parameters for differential diagnosing hemangiomas, benign soft tissue tumors excluding hemangiomas (BSTTEHs), and STSs.
PATIENTS AND METHODS
Patients
The study was approved by the Institutional Ethics Committee of First Affiliated Hospital of Dalian Medical University (Dalian, China). Thirty-one consecutive patients were enrolled in this study and inspected conventional MR and IVIM-MR examination with 3.0-T MR imager from October 2013 to October 2014. Eight of these patients were excluded for further analysis: 4 patients did not receive surgery and there were no pathological results available; 1 tumor in the upper limb was close to artery and the quality of image was very poor; and for other 3 patients, there were no sufficient regions of interest (ROI) areas for IVIM analysis. As a result, only 23 STTs were further analyzed. Primary sites and clinical data of these tumors (11 female, 12 male; average age, 44 years; age range 16–85 years) were described in Table 1.
TABLE 1.
Conventional MR Imaging
MRI was performed using a 3.0-T MR imager (Signa, HDxt, 3.0 T; General Electric Healthcare, Milwaukee, WI) with surface coil (limbs with 3 inch coil, shoulder with shoulder coil or soft coil, and torso and hips with body coil). The conventional MR scanning sequences included spin echo (SE) T1WI (repetition time/echo time [TR/TE], 650 ms/min full; reconstruction matrix size, 288 × 224; slice thickness/slice spacing, 4–6 mm/0–1 mm), fast spin echo (FSE) T2WI (TR/TE, 3975 ms/68 ms; number of signals acquired, 4; reconstruction matrix size, 256 × 224; slice thickness/slice spacing, 4–6 mm/0–1 mm), fat suppression T2WI and PDWI (TR/TE, 2000 ms/42 ms; number of signals acquired, 3; reconstruction matrix size, 256 × 224; slice thickness/slice spacing, 4–6 mm/0–1 mm). If necessary, fat suppression T1WI was performed. Field of view (FOV), which could be changed according to the tumors’ size, was 15 to 40 cm with slice thickness 4 to 6 mm and space 0 to 1 mm.
IVIM MR Imaging
IVIM scan was performed using spin-echo echo-planar imaging (SE-EPI) sequence (TR/TE, 8000 ms/min; NEX, 8; reconstruction matrix size, 128 × 128; slice thickness, slice spacing, and FOV similar to conventional scan; 10 b values [0, 10, 20, 30, 50, 100, 200, 300, 500, and 800 s/mm2]). In order to eliminate the influence of the anisotropy for the IVIM signal and the numerical measurement, 3 in 1 was applied. All patients were fixed on bed to prevent the influence of movement.
Based on IVIM theory, the bi-exponential model was expressed by the following equation:11
where Sb is the signal intensity in the pixel with diffusion gradient b, S0 the signal intensity in the pixel without diffusion gradient (b of 0 s/mm2), f the fractional perfusion related to the microcirculation, ADCslow the true diffusion coefficient as reflected by pure molecular diffusion, and ADCfast is the pseudo-diffusion coefficient representing perfusion-related diffusion or incoherent microcirculation.
Dynamic Contrast-Enhanced MR Imaging
Dynamic contrast-enhanced MR imaging was performed using 2-dimensional fast spoiled gradient echo sequence (2D FSPGR). The contrast agent gadolinium-DTPA (Magnevist, Berlex, New Jersey) was injected as 0.l mmol/kg, and 2.5 mL/s. And 10 mL saline was additionally injected at the same velocity.
Regions of Interest (ROI)
ROI was placed on the parenchyma of each tumor in DWI. Large cystic or necrotic areas and large vessels were not included. The mean ROI area was about 15.0 ± 1.21 mm2. Three ROIs in each image and totally 9 ROIs in 3 consecutive images of IVIM were calculated for each patient. The different values (ADCstandard, ADCslow, ADCfast, and f) of STTs were measured in GE-ADW 4.4 workstation.
Statistical Analysis
Two independent-sample t-test was used for assessing ADCslow and ADCfast of hemangiomas, BSTTEHs, and STSs separately. One-way ANOVA and least significant difference (LSD) t-test were used for comparing IVIM parameters among the 3 types of STTs. Receiver operating characteristic (ROC) curves were generated with respective cut-off values determined to accommodate best diagnostic accuracy based on the Youden index. SPSS (version19.0, Chicago, IL) was used for statistical analysis. P values < 0.05 were considered significant for 2-tailed probability.
RESULTS
In total, ROIs from 8 hemangiomas, 11 BSTTEHs, and 4 STSs were evaluated. The mean tumor size (maximum tumor areas measured using axial contrast-enhanced MR images) was 1652.36 ± 233.66 mm2. ADCslow and ADCfast value were different among hemangiomas, BSTTEHs, and STSs separately (P < 0.001, P < 0.001, and P = 0.001).
Each IVIM parameter (ADCstandard, ADCslow, ADCfast, and f) for STTs was significant difference (P < 0.001, P = 0.001, P < 0.001, and P < 0.001) (Table 2, Figures 3–5). Multiple comparisons of IVIM parameters between each index are summarized in Table 3. The ADCstandard, ADCfast, and f values of hemangiomas and STSs or BSTTEHs and STSs were significant difference (P < 0.05), while there was no significant difference for these 3 parameters between hemangiomas and BSTTEHs (P = 0.584, P = 0.907, and P = 0.798). The ADCslow values between hemangiomas and BSTTEHs, hemangiomas and STSs, and also BSTTEHs and STSs were significant difference (P = 0.014, P = 0.036, and P < 0.001).
TABLE 2.
TABLE 3.
The ROC curves and optimal cut-off values of IVIM parameters were used to identify STSs from STTs (Figure 1 and Table 4). The ADCslow value was the most powerful parameter, with area under the curve of 0.86, followed by ADCstandard 0.72 and f 0.56. ADCfast was the least meaningful one with area 0.34. The ROC curve and optimal cut-off value of ADCslow were used to discriminate hemangiomas from BSTTs in Figure 2 and Table 5. The optimal cut-off value was between 0.93 × 10−3 and 0.96 × 10−3 mm2/s. Two steps to deal with STTs were indicated in Table 6. First step was to separate BSTTs (Figures 3 and 4) from STSs (Figure 5), and then to identify hemangiomas (Figure 3) from BSTTs.
TABLE 4.
TABLE 5.
TABLE 6.
DISCUSSION
There are similar imaging characteristics (such as diffuse growth, easy to relapse, and high signal intensity on T2-weighted imaging/DW-MRI) for hemangiomas and malignant tumors. This is the main reason for radiological and clinical misdiagnosing hemangiomas as malignant tumors. So hemangiomas were classified out as a separate group in this study.
IVIM MR imaging has been utilized as an attractive noninvasive imaging technique with the potential for assessing both tissue perfusion and diffusion of STTs using a single DW imaging.10,12 And it shows a unique profile of microcirculation and pure molecular diffusion within tumors. Our study showed that the ADCslow and ADCfast values of hemangiomas, BSTTEHs, and STSs were significantly different, which suggested that IVIM imaging facilitates understanding of tumor tissue characteristics of perfusion and diffusion.
On the other hand, ADCstandard values of hemangiomas, BSTTEHs, and STSs were also significantly different. The ADCstandard of BSTTEHs was maximum (1.555 ± 0.176 × 10−3 mm2/s), while the ADCstandard of STSs was minimum (1.009 ± 0.177 × 10−3 mm2/s) due to active proliferative capacity of sarcomas. The limitation of water molecular diffusion of malignant tumors leads to the decrease of ADC value.13
In the bi-exponential model, ADCslow (P = 0.014) was an effective parameter to distinguish hemangiomas from other benign tumors. ADCslow with a high b value (>200 s/mm2) is the true diffusion coefficient of pure water in tumors with perfusion components removed at the same time. There were significant differences for values of ADCslow among hemangiomas, BSTTEHs, and STSs (Table 3). The value of ADCslow decreased from BSTTEHs to STSs with hemangiomas in the middle level. The reason is that potential proliferation of STSs is faster than BSTTs. For STSs, there are large nuclei, less cytoplasm, and a dense array of cells, which lead to the extracellular space reduced, the cell membrane permeability reduced, and the water molecular diffusion limited.14–17 So ADCslow decreased significantly. According to ROC curve, the cut-off value of ADCslow without perfusion effects is smaller than that of ADCstandard in the bi-exponential of IVIM model. As stated above, ADCslow may be a meaningful parameter for differential diagnosis of hemangiomas, BSTTEHs, and STSs.
Microcirculation perfusion, namely fast moving component in the bi-exponential of IVIM model, is more sensitive to the MR signal attenuation.18 According to the bi-exponential theory, ADCfast is closely related to microvessel density of tumor tissues at low b value (<200 s/mm2). In this study, ADCfast was significantly greater than related ADCslow. It means that ADCfast is sensitive to MR signal attenuation at lower b values. There is a maximum value of ADCfast of STSs as the same results of report12 about ADCfast for different groups (cervical tumor, myometrium, and leiomyoma), which confirmed ADCfast associated with the degree of tissue microvessel perfusion.
The fractional volume of capillary blood flowing in each voxel is measured using f.19 f value may correlate with the amount of normal angiogenesis with intact vessels in terms of basement membrane thickness and pericyte coverage, and it increases with the augmented tissue perfusion components.20 Our results suggest that hemangiomas (0.682 ± 0.060) are rich in capillaries per unit tumor volume, while STSs (0.503 ± 0.068) are relatively poor in capillaries because liposarcomas and extraskeletal myxoid chondrosarcomas are not rich in blood vessels. Therefore, f value may be an indicator of intact vascular permeability.
There are several limitations in this research. First of all, a major limitation of the present study was the small patient cohort of different STTs. Furthermore, IVIM imaging is sensitive to little movement, which may be problematic for thigh IVIM imaging due to pulsation of arteries. Lastly, this study was only to screen out hemangioma from BSTTs, and further research is necessary to differentiate other types of STTs.
CONCLUSION
To our knowledge, this is the first of its kind report about the application of pixel-based IVIM imaging to evaluate heterogeneous STTs. It may provide useful information to discriminate malignant tumors from benign ones regarding patient stratification and strategy in further treatment.
Footnotes
Abbreviations: ADC = apparent diffusion coefficient, BSTTEHs = benign soft tissue tumors excluding hemangiomas, BSTTs = benign soft tissue tumors, DWI = diffusion weighted imaging, MRI = magnetic resonance imaging, STSs = soft tissue sarcomas, STTs = soft tissue tumors.
The authors have no funding and conflicts of interest to disclose.
REFERENCES
- 1.Radaelli S, Stacchiotti S, Casali PG, et al. Emerging therapies for adult soft tissue sarcoma. Expert Rev Anticancer Ther 2014; 14:689–704. [DOI] [PubMed] [Google Scholar]
- 2.Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg Clin North Am 2008; 88:451–481.v. [DOI] [PubMed] [Google Scholar]
- 3.Burningham Z, Hashibe M, Spector L, et al. The epidemiology of sarcoma. Clin Sarcoma Res 2012; 2:14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Varma DG. Optimal radiologic imaging of soft tissue sarcomas. Semin Surg Oncol 1999; 17:2–10. [DOI] [PubMed] [Google Scholar]
- 5.Theumann NH, Bittoun J, Goettmann S, et al. Hemangiomas of the fingers: MR imaging evaluation. Radiology 2001; 218:841–847. [DOI] [PubMed] [Google Scholar]
- 6.Kransdorf MJ, Murphey MD. Radiologic evaluation of soft-tissue masses: a current perspective. Am J Roentgenol 2000; 175:575–587. [DOI] [PubMed] [Google Scholar]
- 7.Pang KK, Hughes T. MR imaging of the musculoskeletal soft tissue mass: is heterogeneity a sign of malignancy? J Chin Med Assoc 2003; 66:655–661. [PubMed] [Google Scholar]
- 8.Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 2008; 249:748–752. [DOI] [PubMed] [Google Scholar]
- 9.Yabuuchi H, Matsuo Y, Kamitani T, et al. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? Radiology 2008; 249:909–916. [DOI] [PubMed] [Google Scholar]
- 10.Sumi M, Van Cauteren M, Sumi T, et al. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 2012; 263:770–777. [DOI] [PubMed] [Google Scholar]
- 11.Le Bihan D, Turner R, MacFall JR. Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 1989; 10:324–337. [DOI] [PubMed] [Google Scholar]
- 12.Lee EY, Yu X, Chu MM, et al. Perfusion and diffusion characteristics of cervical cancer based on intraxovel incoherent motion MR imaging-a pilot study. Eur Radiol 2014; 24:1506–1513. [DOI] [PubMed] [Google Scholar]
- 13.Kallehauge JF, Tanderup K, Haack S, et al. Apparent diffusion coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: dependence on b-values used. Acta Oncol (Stockholm, Sweden) 2010; 49:1017–1022. [DOI] [PubMed] [Google Scholar]
- 14.Lambregts DM, Maas M, Cappendijk VC, et al. Whole-body diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging. Eur J Cancer (Oxford, England: 1990) 2011; 47:2107–2116. [DOI] [PubMed] [Google Scholar]
- 15.Mueller-Lisse UG, Mueller-Lisse UL, Zamecnik P, et al. [Diffusion-weighted MRI of the prostate]. Der Radiol 2011; 51:205–214. [DOI] [PubMed] [Google Scholar]
- 16.Tan CH, Wang J, Kundra V. Diffusion weighted imaging in prostate cancer. Eur Radiol 2011; 21:593–603. [DOI] [PubMed] [Google Scholar]
- 17.Giannarini G, Petralia G, Thoeny HC. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Eur Urol 2012; 61:326–340. [DOI] [PubMed] [Google Scholar]
- 18.Dyvorne HA, Galea N, Nevers T, et al. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters – a pilot study. Radiology 2013; 266:920–929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992; 27:171–178. [DOI] [PubMed] [Google Scholar]
- 20.Lewin M, Fartoux L, Vignaud A, et al. The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 2011; 21:281–290. [DOI] [PubMed] [Google Scholar]